Old Web
English
Sign In
Acemap
>
authorDetail
>
Vanita K. Pindolia
Vanita K. Pindolia
Henry Ford Health System
Medicine
Anesthesia
Internal medicine
Health care
Biosimilar
5
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High-Neutropenia Risk Chemotherapy.
2021
Journal of The National Comprehensive Cancer Network
Pamala A. Pawloski
Cara L. McDermott
James Marshall
Vanita K. Pindolia
Catherine M. Lockhart
Catherine A. Panozzo
Jeffrey S. Brown
Bernadette Eichelberger
Show All
Source
Cite
Save
Citations (0)
Evaluating biologics and their biosimilars using a distributed research network to demonstrate real-world outcomes.
2018
Pamala A. Pawloski
Kevin Haynes
Daniel J. Kent
Cheryl N. McMahill-Walraven
Catherine A. Panozzo
Vanita K. Pindolia
Catherine M. Lockhart
Jeffrey R. Brown
Aaron B. Mendelsohn
Charles E. Barr
Bernadette Eichelberger
Show All
Source
Cite
Save
Citations (0)
Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative
2017
Journal of Managed Care Pharmacy
Michael D. Tarantino
Vanita K. Pindolia
Show All
Source
Cite
Save
Citations (2)
Mitigation of Medication Mishaps via Medication Therapy Management
2009
Annals of Pharmacotherapy
Vanita K. Pindolia
Lesia Stebelsky
Tanya M. Romain
Lori Luoma
Sandra N Nowak
Fadwa Gillanders
Show All
Source
Cite
Save
Citations (51)
Imatinib mesylate, the first molecularly targeted gene suppressor.
2002
Pharmacotherapy
Vanita K. Pindolia
Barbara J. Zarowitz
Show All
Source
Cite
Save
Citations (14)
1